Добірка наукової літератури з теми "HCT 116 Carcinoma"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "HCT 116 Carcinoma".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "HCT 116 Carcinoma"
Apaydin Yildirim Betul. "Anti-cancer, antiproliferative activity of active anionic H2O8 oxygen solution on HCT-116 cancer cell." World Journal of Advanced Research and Reviews 12, no. 2 (November 30, 2021): 179–84. http://dx.doi.org/10.30574/wjarr.2021.12.2.0560.
Повний текст джерелаLeong, Lek Mun, Kok Meng Chan, Asmah Hamid, Jalifah Latip, and Nor Fadilah Rajab. "Herbal Formulation C168 Attenuates Proliferation and Induces Apoptosis in HCT 116 Human Colorectal Carcinoma Cells: Role of Oxidative Stress and DNA Damage." Evidence-Based Complementary and Alternative Medicine 2016 (2016): 1–12. http://dx.doi.org/10.1155/2016/2091085.
Повний текст джерелаLeischner, Christian, Markus Burkard, Anja Michel, Susanne Berchtold, Heike Niessner, Luigi Marongiu, Christian Busch, Jan Frank, Ulrich M. Lauer, and Sascha Venturelli. "Comparative Analysis of the Antitumor Activity of Cis- and Trans-Resveratrol in Human Cancer Cells with Different p53 Status." Molecules 26, no. 18 (September 14, 2021): 5586. http://dx.doi.org/10.3390/molecules26185586.
Повний текст джерелаChandrani, Jeenkal P., and Kalpesh J. Ganatra. "An Efficient And Catalytically Free Chemical Transformation of Pyrimidin-2(1H)-one to 2-(N-Arylamino)pyrimidines and their in vitro Cytotoxicity Evaluation." Asian Journal of Organic & Medicinal Chemistry 5, no. 2 (2020): 133–37. http://dx.doi.org/10.14233/ajomc.2020.ajomc-p260.
Повний текст джерелаTan, Maria Carmens, Glenn G. Oyong, Chien Chang Shen, and Consolacion Y. Ragasa. "CYTOTOXIC LABDANE DITERPENOIDS FROM ANDROGRAPHIS PANICULATA (BURM.F.) NEES." Asian Journal of Pharmaceutical and Clinical Research 10, no. 12 (December 1, 2017): 99. http://dx.doi.org/10.22159/ajpcr.2017.v10i12.19194.
Повний текст джерелаBudu, Oana, Christian Dragos Banciu, Codruta Soica, Daniel Florin Lighezan, Andreea Milan, Alexandra Prodea, Alexandra Mioc, Marius Mioc, Gabriel Mardale, and Laurentiu Sima. "Lacticaseibacillus rhamnosus—A Promising Tool for Colorectal Cancer Treatment." Processes 11, no. 3 (March 6, 2023): 781. http://dx.doi.org/10.3390/pr11030781.
Повний текст джерелаVaziri, S. A., A. Al-Hazzouri, D. R. Grabowski, M. K. Ganapathi, R. M. Bukowski, and R. Ganapathi. "Sorafenib treatment of clear-cell renal cell carcinoma (CCRCC) and colorectal carcinoma (CRC) cells: Differential effects on gene expression and cell death pathways." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 15612. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.15612.
Повний текст джерелаKhulud M Alshehr and Madeha O I Ghobashy. "Antitumor, Antimicrobial activities and Phytochemicals Constituent of different Extracts of Pulicaria undulata (Forssk.) Oliver. Grown Naturally in Saudi Arabia." International Journal of Research in Pharmaceutical Sciences 11, no. 3 (August 11, 2020): 4889–901. http://dx.doi.org/10.26452/ijrps.v11i3.2790.
Повний текст джерелаKanti Das, Sabuj, Snehasis Mishra, Krishnendu Manna, Utpal Kayal, Supratim Mahapatra, Krishna Das Saha, Sasanka Dalapati, G. P. Das, Amany A. Mostafa та Asim Bhaumik. "A new triazine based π-conjugated mesoporous 2D covalent organic framework: itsin vitroanticancer activities". Chemical Communications 54, № 81 (2018): 11475–78. http://dx.doi.org/10.1039/c8cc07289b.
Повний текст джерелаJacinto, Sonia D., Eunice Alexis C. Chun, Anthony Sebastian Montuno, Chien-Chang Shen, Dinah L. Espineli, and Consolacion Y. Ragasa. "Cytotoxic Cardenolide and Sterols from Calotropis Gigantea." Natural Product Communications 6, no. 6 (June 2011): 1934578X1100600. http://dx.doi.org/10.1177/1934578x1100600614.
Повний текст джерелаДисертації з теми "HCT 116 Carcinoma"
Kashyap, Srishti. "Isolation, Structure Elucidation and Functional Characterization of a Novel Cytotoxic Secondary Metabolite Phomafuranone, 2-Hydroxy-2, 4-dimethyl-5-[-1-propen-1-yl]-3(2H)-furanone, from Phoma tropica an Endophytic Fungus Isolated from Mappia foetida." Thesis, 2017. http://etd.iisc.ac.in/handle/2005/4135.
Повний текст джерелаChung, Ming-Hsien, and 鍾明憲. "Positron Emission Tomography-based study in Hepatocellular carcinoma: 18F-FDG and 11C-MET uptake in HCC cell line." Thesis, 2011. http://ndltd.ncl.edu.tw/handle/78026005703905063226.
Повний текст джерела國防醫學院
生物及解剖學研究所
99
Hepatocellular carcinoma (primary liver malignancy or called hepatoma) is the most common type of liver cancer. In Taiwan, the incidence of hepatoma has been estimated to be 27.7 of 100,000 peoples every year. It ranks the first and second cancer-related death in male and female, respectively. The clinical assessment tools for patients with hepatoma include serum alpha-fetoprotein (AFP) check up and several modalities of imaging study. The latter ones consist of sonography, computed tomography (CT), magnetic resonance imaging (MRI) and positron emission tomography (PET). Among which, PET is useful to survey tumor metabolism by using different tracers. In clinical practice 18F-Fluoro-deoxyglucose (FDG) is the most commonly used oncological PET tracer. Most cancer cells can accumulate FDG via membrane glucose transporter and phosphorylation of FDG by enriched hexokinase expression, thus allowing the FDG-avid tumor cells to be detected by PET. However FDG is not a completely satisfied tracer for hepatomas because of the various expression of glucose-6-dephosphatase (G6PD) inherent to hepatocytes, which may evacuate the tracer from tumor cells once FDG is de-phosphorylated by G6PD. The G6PD activity varies in hepatomas with different differentiation and therefore affects the detection rate of FDG PET. Alternative PET tracers such as 11C-acetate and 11C-choline have been proposed and their use to detect certain non-FDG-avid hepatomas has been reported preliminarily. Our previous study has demonstrated the use of 11C-methionine (Met) to localize hepatomas. Briefly we found that the primary hepatomas showed Met-void while extra-hepatic hepatomas presented as Met-avid lesions. Conversely the intra-hepatic Met-void lesion showed FDG avidity. To further explore the related mechanism, the study of in vitro Met uptake in hepatomas was performed using three different cell lines (HepG2, Hep3B, HA59T). Also two known differentiation modifiers including All-trans retinoic acid (ATRA) and Trichostatin A (TSA) were adopted to intervene the hepatomas. Met and FDG uptake in ATRA- or TSA-treated hepatomas were compared and correlated with the pertinent tumor growth. The result showed that all these three cell-lines shared the response of growth arrest as well as increased apoptotic potential with either ATRA or TSA treated hepatoma cells in vitro. Their FDG uptake was significantly lowered and Met uptake was enhanced in presence of TSA. The change followed a dose-depend manner. With ATRA treatment, dose-dependent increased Met uptake was also demonstrated in hepatomas. However there was similar change of FDG uptake in ATRA-treated hepatomas. In conclusion Met uptake in hepatomas can be regulated by ATRA or TSA treatment and whether it is related to the effects of differentiation or anti-tumor activity known for ATRA or TSA remains uncertain. The role of Met uptake as a biomarker for hepatoma therapeutics related research warrants for further study.
Тези доповідей конференцій з теми "HCT 116 Carcinoma"
Šeklić, Dragana, Milena Jovanović, Nevena Milivojević, and Marko Živanović. "PLATINUM(IV) COMPLEX AND ITS CORRESPONDING LIGAND SUPPRESS CELL MOTILITY AND PROMOTE EXPRESSION OF FRIZZLED-7 RECEPTOR IN COLORECTAL CANCER CELLS." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac, 2021. http://dx.doi.org/10.46793/iccbi21.288s.
Повний текст джерелаMilenković, Dejan A., Marko N. Živanović, Milan S. Dekić, Marijana Stanojević Pirković, and Jelena R. Đorović Jovanović. "CYTOTOXIC ACTIVITY AND MOLECULAR DOCKING STUDY OF 4- SUBSTITUTED FLAVYLIUM SALT." In 1st INTERNATIONAL Conference on Chemo and BioInformatics. Institute for Information Technologies, University of Kragujevac,, 2021. http://dx.doi.org/10.46793/iccbi21.466m.
Повний текст джерелаEkine-Afolabi, Bene Akromaa, Sandra Appiah, Azra Pachenari, and Lucy Ghali. "Abstract LB-271: Inulin inhibits free radical species in HCT 116 adenoma carcinoma and normal human HK (keratinocyte) cell line." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-lb-271.
Повний текст джерелаPogorzelska, Aneta, Jarosław Sławiński, and Anna Kawiak. "New N-Benzenesulfonylguanidine Derivatives and Their Selective Growth Inhibition of Human Breast Cancer Cell Line MCF-7 and Colon Carcinoma HCT-116." In ECMC 2022. Basel Switzerland: MDPI, 2022. http://dx.doi.org/10.3390/ecmc2022-13281.
Повний текст джерелаLee, Michael J., Robert J. M. Frey, Steven D. Frey, Anthony H. Yeo, Janna M. Vassantachart, Peter S. Han, Sara E. Stump, Ying Ming B. Tan, Randy P. Hausted, and Brian YY Wong. "Abstract LB-21:Taraxacum officinale(common dandelion) inhibits azoxymethane-induced aberrant crypt foci formation in C67BL/6 mice and regulates apoptosis in mice and in human colorectal carcinoma HCT-116 cells." In Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1538-7445.am2011-lb-21.
Повний текст джерелаHotta, Naoki. "IDDF2023-ABS-0005 Hepatocellular carcinoma (HCC) treatment experience using smart fusion in dialysis patients." In Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 10–11 June 2023. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2023. http://dx.doi.org/10.1136/gutjnl-2023-iddf.123.
Повний текст джерелаXu, Ming Jing, Kit Ho Lai, Shu Hai Lin, Pui Wah Tse, David Kung Chun Chiu, Hui Yu Koh, Cheuk Ting Law, et al. "Abstract 1058: Targeting pentose phosphate pathway (PPP) represents a novel therapeutic strategy for hepatocellular carcinoma (HCC) treatment." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-1058.
Повний текст джерелаCheo, Feng-Yi, Kai-Siang Chan, Wei-Xuan Tay, and Vishal Shelat. "IDDF2022-ABS-0193 Outcomes of preoperative transarterial chemoembolization (TACE) compared to upfront liver resection for large (≥5cm) hepatocellular carcinoma (HCC): a systematic review and meta-analysis." In Abstracts of the International Digestive Disease Forum (IDDF), Hong Kong, 2–4 September 2022. BMJ Publishing Group Ltd and British Society of Gastroenterology, 2022. http://dx.doi.org/10.1136/gutjnl-2022-iddf.119.
Повний текст джерелаEl-Khoueiry, Anthony, Mary F. Mulcahy, Tanios Bekaii-Saab, Richard Kim, Crystal Denlinger, Rakesh Goel, Shweta Gupta, et al. "Abstract 2947: Pharmacodynamic (PD) and pharmacokinetic (PK) results of the second-generation hypomethylating agent, SGI-110, in patients with hepatocellular carcinoma (HCC) after progression on sorafenib." In Proceedings: AACR 106th Annual Meeting 2015; April 18-22, 2015; Philadelphia, PA. American Association for Cancer Research, 2015. http://dx.doi.org/10.1158/1538-7445.am2015-2947.
Повний текст джерелаTrochon-joseph, Véronique, Caroline Lemarchand, Vincent Hayes, Yamina Rayah, Jean-Louis Labernardière, and Graham Dixon. "Abstract 2143: Mechanistic study of the relative cytotoxicity of doxorubicin loaded nanoparticle formulation compared to free doxorubicin in hepatocellular carcinoma (HCC) cell lines." In Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/1538-7445.am2016-2143.
Повний текст джерела